Benzinga | Nov 5, 2020 08:38AM EST

Heron Therapeutics Q3 EPS $(0.64) Down From $(0.42) YoY, Sales $19.96M Down From $42.62M YoY

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.64) per share. This is a 52.38 percent decrease over losses of $(0.42) per share from the same period last year. The company reported $19.96 million in sales this quarter. This is a 53.16 percent decrease over sales of $42.62 million the same period last year.